Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study
Open Access
- 10 April 2017
- journal article
- research article
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 16 (4) , 315-320
Abstract
To evaluate efficacy and safety of 20 000 IU cholecalciferol weekly in HIV-infected patients. Longitudinal data for 243 HIV-infected patients with paired 25-OH-vitamin D3 values for the same month in 2 consecutive years were stratified by the initiation of supplementation in this retrospective study. After 1 year of administration of cholecalciferol 20 000 IU weekly, about 78% of patients with initial vitamin D level 20 µg/L and 42% achieved levels >30 µg/L. Supplemented patients with baseline vitamin D levels P = .006; risk difference: 20.8%) and a significantly lower increase in alkaline phosphatase (AP) compared to those in the nonsubstituted group. The dose of 20 000 IU of cholecalciferol once weekly was found to be safe and effective. Normalization of vitamin D levels within 1 year was observed in 42% to 75% of the patients.Keywords
This publication has 19 references indexed in Scilit:
- Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive personsHIV Medicine, 2015
- An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot studyEndocrine, 2015
- Personal Sun Exposure and Serum 25‐hydroxy Vitamin D ConcentrationsPhotochemistry and Photobiology, 2012
- High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort studyAIDS, 2010
- High prevalence of reduced bone mineral density in primary HIV-1-infected menAIDS, 2010
- Annual High-Dose Oral Vitamin D and Falls and Fractures in Older WomenJAMA, 2010
- Effect of annual intramuscular vitamin D on fracture risk in elderly men and women a population-based, randomized, double-blind, placebo-controlled trialRheumatology, 2007
- Low Vitamin D Status despite Abundant Sun ExposureThe Journal of Clinical Endocrinology & Metabolism, 2007
- Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic reviewAIDS, 2006
- Effects of Above Average Summer Sun Exposure on Serum 25-Hydroxyvitamin D and Calcium AbsorptionThe Journal of Clinical Endocrinology & Metabolism, 2002